Regimens antineoplastic agents. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Tumor Cells, Cultured Cell Line, Tumor HL-60 Cells Cell Line Cells, Cultured HT29 Cells

Organisms7

Narcissus Mice, Nude Aster Plant Olacaceae Mice, Inbred BALB C Mice, SCID Mice, Inbred C57BL

Diseases36

Leukemia P388 Neoplasms Sarcoma 180 Leukemia L1210 Neoplasms, Experimental Lung Neoplasms Breast Neoplasms Leukemia Ovarian Neoplasms Colonic Neoplasms Prostatic Neoplasms Phlebitis Nausea Vomiting Carcinoma, Ehrlich Tumor Lymphoma, Non-Hodgkin Leukopenia HIV Infections Neoplasm Metastasis Neutropenia Adenocarcinoma Lymphoma Colorectal Neoplasms Multiple Myeloma Brain Neoplasms Drug-Related Side Effects and Adverse Reactions Recurrence Thrombocytopenia Mammary Neoplasms, Experimental Disease Progression Glioma Melanoma Disease Models, Animal Carcinoma, Non-Small-Cell Lung Bone Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma

Chemicals and Drugs115

Antineoplastic Agents Antineoplastic Agents, Phytogenic Amaryllidaceae Alkaloids Doxorubicin Ellipticines Bibenzyls Antibiotics, Antineoplastic Thiadiazines Bryostatins Antineoplastic Agents, Alkylating Ancitabine Cisplatin Gallium Paclitaxel Depsipeptides 6-Mercaptopurine Epothilones Aminoacridines Fluorouracil Antimetabolites, Antineoplastic Etoposide Lactones Daunorubicin Bleomycin Methotrexate Prodrugs Vincristine Cyclophosphamide Camptothecin Macrolides Stilbenes Enzyme Inhibitors Isoquinolines Taxoids Caspases DNA RNA, Messenger Phospholipid Ethers Reactive Oxygen Species Cytarabine Sulindac Deoxycytidine Vinblastine Carmustine Organoplatinum Compounds Amsacrine Anti-Bacterial Agents Ifosfamide Vanadium Compounds Anti-HIV Agents Floxuridine Thiosemicarbazones Drug Combinations Melphalan Mitomycin Drugs, Investigational Anthracyclines Hazardous Substances Pyrazines Mitoxantrone Carboplatin Nitrogen Mustard Compounds 2-Propanol Antibodies, Monoclonal, Humanized Topoisomerase II Inhibitors Lomustine Farnesyltranstransferase Dacarbazine Sulfonamides Antibodies, Monoclonal Prednisone Dexamethasone Dioxoles Topotecan Isocoumarins Suramin Anti-Inflammatory Agents, Non-Steroidal Boronic Acids Topoisomerase I Inhibitors Azacitidine Plant Extracts Nitrosourea Compounds Leucovorin Pyrones Mitomycins Immunosuppressive Agents Alkaloids Piperazines DNA Topoisomerases, Type II DNA Adducts Alkylating Agents Busulfan Sesquiterpenes Angiogenesis Inhibitors Benzoxazines Vidarabine Antitubercular Agents HIV Protease Inhibitors Razoxane DNA, Neoplasm P-Glycoprotein Diphosphonates Phosphorylcholine Pyridines Recombinant Proteins Octreotide Hydrazones Glutathione Transferase Rifampin Histone Deacetylase Inhibitors Ritonavir Tetrahydroisoquinolines Pyrroles Organometallic Compounds Drug Carriers

Analytical, Diagnostic and Therapeutic Techniques and Equipment52

Drug Screening Assays, Antitumor Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Drug Evaluation Drug Evaluation, Preclinical Xenograft Model Antitumor Assays Neoplasms, Experimental Treatment Outcome Clinical Trials as Topic Neoplasm Transplantation Drug Therapy, Combination Gloves, Protective Infusions, Intravenous Combined Modality Therapy Protective Devices Administration, Oral Survival Analysis Equipment and Supplies, Hospital Protective Clothing Antineoplastic Protocols Inhibitory Concentration 50 Retrospective Studies Survival Rate Drug Compounding Tumor Stem Cell Assay Disease-Free Survival Comet Assay Transplantation Conditioning Remission Induction Salvage Therapy Injections, Intravenous Randomized Controlled Trials as Topic Prospective Studies Treatment Failure Prognosis Lethal Dose 50 Antiretroviral Therapy, Highly Active Blotting, Western Follow-Up Studies Hematopoietic Stem Cell Transplantation Mutagenicity Tests Flow Cytometry Mammary Neoplasms, Experimental Microbial Sensitivity Tests Transplantation, Heterologous Double-Blind Method Disease Models, Animal Injections, Intraperitoneal Drug Delivery Systems Chromatography, High Pressure Liquid Viral Load Drug Carriers

Psychiatry and Psychology1

Patient Compliance

Phenomena and Processes27

Drug Synergism Apoptosis Cell Survival Molecular Structure Dose-Response Relationship, Drug Drug Resistance, Neoplasm Cell Division Drug Resistance Cell Cycle Time Factors Cell Proliferation Drug Interactions Biotransformation DNA Damage Stereoisomerism Kinetics Structure-Activity Relationship Dental Physiological Processes Inhibitory Concentration 50 Drug Resistance, Multiple Half-Life Gene Expression Regulation, Neoplastic DNA Adducts Lethal Dose 50 Metabolic Detoxication, Drug Cell Death Viral Load

Disciplines and Occupations1

Oncology Nursing

Technology, Industry, Agriculture4

Gloves, Protective Laundering Protective Devices Protective Clothing

Information Science1

Named Groups5

Medical Secretaries Nursing Staff, Hospital Personnel, Hospital Nurses Pharmacists

Health Care27

Treatment Outcome Clinical Trials as Topic Occupational Exposure Medical Secretaries Oncology Nursing Survival Analysis Equipment Contamination Decontamination Antineoplastic Protocols Nursing Staff, Hospital Retrospective Studies Environmental Monitoring Survival Rate Personnel, Hospital Pharmacies Disease-Free Survival Oncology Service, Hospital Nurses Hospitals Randomized Controlled Trials as Topic Prospective Studies Treatment Failure Pharmacists Follow-Up Studies Patient Compliance Double-Blind Method Cancer Care Facilities

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Technology, Industry, Agriculture Information Science Named Groups Health Care

Antineoplastic Agents Antineoplastic Agents, Phytogenic Leukemia P388 Amaryllidaceae Alkaloids Doxorubicin Narcissus Ellipticines Bibenzyls Drug Screening Assays, Antitumor Antibiotics, Antineoplastic Thiadiazines Bryostatins Antineoplastic Agents, Alkylating Neoplasms Ancitabine Cisplatin Gallium Paclitaxel Tumor Cells, Cultured Depsipeptides 6-Mercaptopurine Drug Synergism Antineoplastic Combined Chemotherapy Protocols Apoptosis Cell Line, Tumor Epothilones Aminoacridines Cell Survival Fluorouracil Molecular Structure Sarcoma 180 Dose-Response Relationship, Drug Drug Administration Schedule Antimetabolites, Antineoplastic Etoposide Lactones Daunorubicin Leukemia L1210 Bleomycin Drug Evaluation Drug Resistance, Neoplasm Methotrexate Drug Evaluation, Preclinical Prodrugs Vincristine Cell Division Xenograft Model Antitumor Assays Cyclophosphamide Camptothecin Drug Resistance Neoplasms, Experimental Macrolides Lung Neoplasms Stilbenes Cell Cycle Time Factors Treatment Outcome Mice, Nude Enzyme Inhibitors Cell Proliferation Clinical Trials as Topic HL-60 Cells Drug Interactions Breast Neoplasms Isoquinolines Neoplasm Transplantation Biotransformation Taxoids Leukemia Ovarian Neoplasms DNA Damage Stereoisomerism Kinetics Cell Line Colonic Neoplasms Caspases Prostatic Neoplasms Drug Therapy, Combination DNA Structure-Activity Relationship RNA, Messenger Phospholipid Ethers Cells, Cultured Reactive Oxygen Species Gloves, Protective Aster Plant Cytarabine Occupational Exposure Olacaceae Medical Secretaries Infusions, Intravenous Oncology Nursing Combined Modality Therapy Sulindac Laundering Protective Devices Dental Physiological Processes Deoxycytidine Administration, Oral Vinblastine

No FAQ available that match "regimens antineoplastic agents"